Latest Statistics and Forecasts Regarding the Sleep Disorders Market: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking

Business Wire, March 03, 2009

NEW YORK -- Reportlinker.com announces that a new market research report is available in its catalogue.

Sleep Disorders: Insomnia, Sleep Apnea, Restless Leg Syndrome, Bruxism, Narcolepsy and Sleepwalking

http://www.reportlinker.com/p0105654/Sleep-Disorders-Insomnia-Sleep-Apnea-Restless-Leg-Syndrome-Bruxism-Narcolepsy-and-Sleepwalking.html

Insomnia, sleep apnea, restless leg syndrome, bruxism, narcolepsy and sleepwalking are all serious sleep disorders that possess negative—and sometimes fatal—health consequences. Often undiagnosed and thus not treated, sleep disorders can not only take a toll on personal health but can also adverse effects on personal relationships and reduce worker productivity. In examining the troubling increase in a variety of sleep disorders, this publication report will analyze the causes and available treatments for sleep disorder sufferers. This is a particularly interesting time in the evolution of the sleep disorders market because the blockbuster drugs that have dominated this space are coming off patent protection. There has been a strong push on the part of the major pharmaceutical companies to develop or acquire replacement sources of revenue. In order to put sleep disorders in a proper context, the study begins with an examination of key characteristics of the overall sleep disorders market. The types of disorders, causes of insomnias, parasomnias and their treatments are analyzed, with the additional review of treatments including pharmaceuticals, devices (continuous positive airway pressure or CPAP machines) and others (nutraceuticals, etc.). The report goes on to describe the primary product offerings of the major companies in this market space including major classes of prescription and over-the-counter (OTC) pharmaceuticals. Finally, a review of companies developing treatments for insomnia, sleep apnea, restless leg syndrome, bruxism, narcolepsy and sleepwalking are examined.

Table of Contents:

1. Overview 9

1.1 Statement of Report 9

1.2 About This Report 9

1.3 Scope of the Report 10

1.4 Methodology 10

1.5 Executive Summary 11

1.6 U.S. Sleep Market 14

1.6.1 Sleep Drugs Market in the U.S. 14

1.6.2 U.S. Sleep Apnea Devices Market 15

1.6.3 U.S. Market for Mattresses and Other related Products 15

1.6.4 Sleep Laboratories in the U.S. 16

1.6.4.1 Locate Sleep Centers in the U.S. 18

1.7 Future of Sleep Drugs 19

1.7.1 Sleep Drugs for Jet Lag and Shift Work 19

1.7.2 Sleep Drugs for Age-related Sleep Issues 20

1.7.3 Sleep Drugs for Those Who Cannot Sleep Through the Night 21

1.7.4 Sleep Drugs for Restless Leg Syndrome 21

1.7.5 Sleep Drugs for Insomnia 22

1.7.6 Sleep Drugs for Sleep Apnea 22

2. Introduction to Sleep Disorders 23

2.1 Sleep Disorders Overview 23

2.1.1 Sleep Facts from the U.S. 24

2.1.2 Consequences of Sleep Disorder Problems 24

2.2 Physiology of Sleep 24

2.2.1 Sleep Stages 25

2.2.2 Neutral Control of Sleep 26

2.3 Current Understanding of Sleep Disorders 26

2.3.1 Hypersomnia 27

2.3.1.1 Causes of Hypersomnia 27

2.3.1.2 Demographics of Hypersomnia 27

2.3.1.3 Treatment for Hypersomnia 28

2.4 Obstructive Sleep Apnea (OSA) 30

2.4.1 Causes of Sleep Apnea 30

2.4.2 Symptoms of Sleep Apnea 31

2.4.3 Demographics of Sleep Apnea 31

2.4.4 Diagnosis of Sleep Apnea 31

2.4.5 Treatments 32

2.4.5.1 Positional Therapy 32

2.4.5.2 Behavioral Therapy-Weight Loss 33

2.4.5.3 Oral Appliances 33

2.4.5.4 Surgery for Sleep Apnea 34

2.4.5.5 Nasal Continuous Positive Airway Pressure (CPAP) Therapy 34

2.4.5.6 Medications for Sleep Apnea 34

2.4.6 The National Ambulatory Medical Care Survey on Sleep Apnea 35

2.4.6.1 Age and Sleep Apnea in Men 38

2.5 Narcolepsy 39

2.5.1 Demographics of Narcolepsy 39

2.5.2 Causes of Narcolepsy 40

2.5.3 Symptoms of Narcolepsy 40

2.5.4 Diagnosis of Narcolepsy 40

2.5.5 Treatment for Narcolepsy 40

2.6 Insomnia 41

2.6.1 Causes of Insomnia 43

2.6.2 Symptoms of Insomnia 43

2.6.3 Demographics of Insomnia 44

2.6.4 Diagnosis of Insomnia 45

2.6.5 Insomnia and Obesity 45

2.6.6 Treatments for Insomnia 47

2.6.6.1 Behavioral Treatment for Insomnia 47

2.6.6.2 Treating Insomnia with Medications 47

2.6.6.3 Alternative Remedies for Insomnia 48

2.6.7 Insomnia Market 48

2.6.8 National Sleep Foundation's "Sleep In America Poll" 52

2.6.8.1 Benzodiazepines 53

2.6.8.2 The Short-term Gold Standard 53

2.6.8.3 Emerging Players 53

2.6.8.4 Insomnia Market Indicators 54

2.6.8.5 Newer Sedative Drugs for Insomnia in 2008 54

2.7 Restless Legs Syndrome 58

2.7.1 Demographics of RLS 59

2.7.2 Causes of RLS 59

2.7.3 Symptoms of RLS 60

2.7.4 Diagnosis of RLS 60

2.7.5 Treatments for RLS 61

2.7.5.1 Lifestyle Changes and RLS 61

2.7.5.2 Treating RLS with Pharmaceuticals 61

2.8 Circadian Rhythm Disorders 62

2.8.1 Causes of Circadian Rhythm Disorders 62

2.8.2 Symptoms 63

2.8.3 Demographics of Circadian Rhythm Disorders 63

2.8.4 Diagnosis of Circadian Rhythm Disorders 63

2.8.5 Treatments for Circadian Rhythm Disorders 64

2.9 Parasomnias 64